Rocket Lab (RKLB) Q2 2026: Record Revenue, Acquisitions Dent EPS
Rocket Lab reported Q2 2026 revenue of $234.07M, above the $230.94M consensus, up 62% year over year. Product revenue rose to $181.35M. GAAP EPS was -$0.08 versus -$0.0767, with the miss linked to $8.6M acquisition-related transaction costs. Backlog grew to $2.36B and Q3 revenue guidance was $250M-$265M.
How this was made

The 30-second read
Why it matters
Traders can update expectations for Q3 revenue based on management’s $250M-$265M guide, while assessing whether GAAP EPS weakness is largely non-recurring versus signaling broader cost pressure. Backlog and cash provide additional support for funding and execution capacity.
Market read
A guidance-backed earnings update with record backlog and cash, plus deal-related transaction costs explaining the GAAP EPS miss.
What to watch
Backlog growth and cash build are supportive, but the text does not quantify margins or free cash flow impact from the acquisitions, nor does it provide Neutron schedule risk beyond a target for Q4 2026 tank production delivery.
Background
Rocket Lab’s Q2 2026 results are framed around product revenue growth, expanding backlog, and deal-related transaction costs tied to Mynaric, Motiv, and a pending Iridium acquisition.
Ticker impact
Rocket Lab reported Q2 2026 revenue of $234.07M, guided Q3 2026 revenue to $250M-$265M, and cited backlog up 137% to $2.36B.
Near-term bias likely positive on revenue, backlog, and cash, partially offset by GAAP EPS weakness tied to deal costs.
The article provides specific Q2 results, explains the GAAP EPS miss as transaction costs, and includes explicit Q3 revenue guidance and backlog/cash figures, which are direct inputs to valuation and near-term expectations.
Market effects
Reinforces demand and execution strength in the space launch and medium-lift reusable rocket segment via record backlog and Neutron production timing.
No specific regional macro linkage stated beyond US-listed company earnings.
Iridium acquisition and integration signals consolidation in satellite communications supply chains, potentially affecting global launch and space services demand expectations.
Counterpoint
GAAP EPS remains negative and the article highlights transaction costs from acquisitions, so investors may discount near-term profitability quality until integration and Iridium deal economics are clearer.
Key entities
- companyRocket Lab
Reported Q2 2026 revenue and GAAP EPS, provided Q3 2026 revenue guidance, and discussed backlog, cash, and Neutron production timing.
- acquired_companyMynaric
Acquisition closed in the quarter; transaction costs contributed to GAAP EPS miss.
- acquired_companyMotiv
Acquisition closed in the quarter; transaction costs contributed to GAAP EPS miss.
- target_companyIridium Communications
Pending acquisition referenced as part of transaction costs and to be detailed on the earnings call.
- product_programNeutron
Medium-lift reusable rocket; Stage 1 tank production targeting delivery to the launch pad in Q4 2026.



